JILL GORE: Open Payments
NPI 1093741332 · FORT SAM HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,127 in 10 payments from 10 companies in 2025. Trend: 2023 $621 · 2024 $1,000 · 2025 $1,127
Food & beverage: $1,127
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 1 | $174 |
| Abbott Laboratories | 1 | $163 |
| Kerecis Limited | 1 | $146 |
| Mirum Pharmaceuticals, Inc. | 1 | $135 |
| Amgen Inc. | 1 | $122 |
| GENZYME CORPORATION | 1 | $121 |
| SANOFI US SERVICES INC. | 1 | $104 |
| Phadia US Inc. | 1 | $82 |
| PFIZER INC. | 1 | $64 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Senza, FREESTYLE LIBRE 3, Kerecis SurgiClose, Livmarli, KRYSTEXXA, DUPIXENT, AYVAKIT, ImmunoCAP.
Industry payments across TX — which companies pay providers there.
